The effects of early short-term insulin treatment vs. glimepiride on beta cell function in newly diagnosed type 2 diabetes with HbA1c above 9%

BACKGROUND/AIM: Type 2 diabetes mellitus (T2D) is a complex metabolic impairment. Beta cell (BC) failure is the most challenging among its pathogenetic mechanisms. Recognizing reversible contributors to BC failure could guide individualized approach to early T2D treatment. The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: STOJANOVIC, Jelena, ANDJELIC JELIC, Marina, VUKSANOVIC, Miljanka, MARJANOVIC PETKOVIC, Milica, JOJIC, Biljana, STOJANOVIC, Marko, BELJIC ZIVKOVIC, Teodora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific and Technological Research Council of Turkey (TUBITAK) 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387975/
https://www.ncbi.nlm.nih.gov/pubmed/37476884
http://dx.doi.org/10.55730/1300-0144.5616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387975/
https://www.ncbi.nlm.nih.gov/pubmed/37476884
http://dx.doi.org/10.55730/1300-0144.5616

Ejemplares similares